Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Structural Bioinformatics receives SBIR grant for asthma treatment

Aug. 26, 1999

MRS-1595: a novel adenosine antagonist selective for the A2B receptor

Aug. 25, 1999

Cystic Fibrosis Foundation awards research grant to PathoGenesis

Aug. 24, 1999

Steroidal "ante drugs" from Affymax have potent activity in the lungs, short half-life in plasma

Aug. 24, 1999

Novel VLA-4 antagonists prepared and evaluated at Novartis

Aug. 24, 1999

Neurokinin receptors with broad potential utility discovered at Schering-Plough

Aug. 20, 1999

SRL-172 shows promising initial results in phase I/II asthma trial

Aug. 20, 1999

Discovery receives Cystic Fibrosis Foundation grant for SuperVent

Aug. 20, 1999

Cell adhesion inhibitor series has potential application in inflammatory and immune disorders

Aug. 18, 1999

Immune Network Research forms JV with Bridge Pharma to develop asthma drug

Aug. 18, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Other news to note for July 22, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...
GSK’s newly acquired Jideytro wins FDA nod in NSCLC
BioWorld
About a week after closing its $10.6 billion acquisition of Nuvalent Inc., GSK plc has reaped the first reward, announcing U.S. FDA approval of zidesamtinib in...
Korea targets generics, innovation in drug pricing overhaul
BioWorld
South Korea is moving ahead with its biggest reform of drug review and pricing in more than a decade, reflecting a wider shift across Asian markets to reward...